Lionsgate, pressured by Carl Icahn's hostile takeover bid, has announced that preliminary results for its fiscal year ended March 31 are 50% better than it forecast two months ago.
Lionsgate will include Carl Ichan as a voter in its upcoming shareholder vote on a poison pill that's designed to make it more difficult for Icahn to complete a hostile takeover of the minimajor.
Lionsgate has rejected Carl Icahn's sweetened offer for the minimajor, a week after the activist investor raised his hostile bid by 17%.
Lionsgate and Carl Icahn are ramping up their battle for control of the minimajor, with both sides campaigning over Lionsgate's proposed "poison pill" provision.
Thanks to Carl Icahn, Lionsgate toppers Jon Feltheimer and Michael Burns find themselves in the spotlight these days.
Saban Capital Group is partnering with Lionsgate on a plan to expand Lionsgate's Tiger Gate pay TV business in Asia.
Lionsgate is urging its shareholders to enact a poison pill provision that would make it far more difficult for Carl Icahn's hostile takeover to succeed.
When Carl Icahn bumped up his investment in Lionsgate to 9% in October 2008, Lionsgate spokesman Peter Wilkes told a reporter, "We welcome his input, which is always very perceptive. He has a great…